Tranylcypromine is a type of medication known as a monoamine oxidase inhibitor (MAOI). It is primarily used in the treatment of major depressive disorder (MDD), especially in cases where other treatments have failed. Its mechanism involves inhibiting the breakdown of monoamine neurotransmitters, thereby increasing their availability in the brain.
